GSK plc Announces Share Transaction
Ticker: GLAXF · Form: 6-K · Filed: Jun 24, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, corporate-action
TL;DR
GSK buying back its own shares, filing shows.
AI Summary
GSK plc announced a transaction in its own shares on June 24, 2025. The company is acting through its corporate stockbroker to execute this transaction, details of which are provided in this Form 6-K filing.
Why It Matters
This filing indicates GSK is actively managing its share capital, which can impact share price and investor perception.
Risk Assessment
Risk Level: low — The filing reports a routine transaction in the company's own shares, which is common corporate activity.
Key Players & Entities
- GSK plc (company) — Registrant
- 001-15170 (company) — Commission File Number
- 20250624 (date) — Filing Date
FAQ
What type of transaction did GSK plc announce?
GSK plc announced a transaction in its own shares.
When was this transaction announced?
The transaction was announced on June 24, 2025.
Who is executing the transaction on behalf of GSK plc?
GSK plc is acting through its corporate stockbroker.
What is the filing type for this announcement?
The filing type is a Form 6-K.
What is GSK plc's principal executive office address?
GSK plc's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 24, 2025 regarding GSK plc (GLAXF).